Atlas Trials

Trimetazidine Efficacy in Attenuating Paclitaxel-Induced Peripheral Neuropathy

Clinical trial NCT06459193 · COMPLETED

Trial details

NCT number
NCT06459193
Sponsor
Minia University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Peripheral Neuropathy Due to Chemotherapy
Start date
2024-06-23
Primary completion
2025-01-28
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.